Compass Therapeutics Q1 2026 Earnings Narrowed Loss and Positive Surprise as Pipeline Progress Continues KVUE Q1 2026 Earnings EPS Surges Past Estimates with 196 Beat YSS Q1 2026 Earnings EPS Misses Estimates by Wide Margin as PreRevenue Stage Continues IIPR Q1 2026 Earnings EPS Misses Estimates as Cannabis Real Estate Yields Mixed Results Riskified Ltd RSKD Q1 2026 Earnings Strong EPS Beat Driven by Operational Discipline RZLT Q1 2026 Earnings Narrower Loss Surpasses Expectations as Clinical Pipeline Advances